ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
66,270.82
0.40%
S&P 500
5,431.60
-0.04%
Dow Jones
38,589.16
-0.15%
US Dollar vs Yen
157.405
-0.01%
Brent Oil
82.275
0.00%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. Endonovo Therapeutics Inc (PK) (ENDV)

  7. Endonovo Therapeutics Inc (PK) (ENDV) ニュース

ENDV

Endonovo Therapeutics (PK) (ENDV)

Endonovo Therapeutics Inc (PK)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:ENDV
日付受信時刻ニュースソース見出しコード企業名
2024/02/0307 : 23Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:ENDVEndonovo Therapeutics Inc (PK)
2024/01/0407 : 30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ENDVEndonovo Therapeutics Inc (PK)
2023/12/3005 : 20Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]USOTC:ENDVEndonovo Therapeutics Inc (PK)
2023/12/0423 : 08Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ENDVEndonovo Therapeutics Inc (PK)
2023/11/1602 : 21Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ENDVEndonovo Therapeutics Inc (PK)
2023/10/1219 : 03Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ENDVEndonovo Therapeutics Inc (PK)
2023/08/2520 : 04Edgar (US Regulatory)Form 1-A/A - Offering Statement [Regulation A]: [Amend]USOTC:ENDVEndonovo Therapeutics Inc (PK)
2023/08/2206 : 16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:ENDVEndonovo Therapeutics Inc (PK)
2023/06/1503 : 27Edgar (US Regulatory)Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2023/05/1619 : 02Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2023/04/1805 : 39Edgar (US Regulatory)Annual Report (10-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2023/04/0104 : 55Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2023/03/2920 : 01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2022/11/1423 : 27Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2022/09/2802 : 31Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2022/08/2222 : 14Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2022/08/1522 : 46Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2022/05/1622 : 01Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2022/05/1107 : 36Edgar (US Regulatory)Amended Registration a Offering Under the Securities Act of 1933 (1-a/a)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2022/04/0105 : 18Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2021/11/1923 : 02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2021/11/1600 : 12Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2021/08/2404 : 06Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2021/08/1623 : 11Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2021/05/2505 : 13Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2021/05/1805 : 45Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2021/04/1406 : 17Edgar (US Regulatory)Annual Report (10-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2021/04/0106 : 01Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2020/11/2006 : 57Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
2020/08/2003 : 44Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ENDVEndonovo Therapeutics Inc (PK)
 Showing the most relevant articles for your search:USOTC:ENDV

最近閲覧した銘柄

AMEX
XLE
Energy Select Sector SPDR
AMEX
XLV
Health Care Select Sector
NYSE
BAC
Bank of America
NYSE
NKE
Nike
NYSE
AXP
American Express
NASDAQ
TSLA
Tesla
FX
USDGBP
US Dollar vs Sterling
SPI
SP500
S&P 500
NASDAQ
AMZN
Amazon.com
PM
XAUUSD
Gold vs US Dollar
AMEX
XLF
Financial Select Sector
USOTC
ADDYY
Adidas (QX)
NYSE
XOM
Exxon Mobil
COIN
BTCUSD
Bitcoin
NYSE
DIS
Walt Disney
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有